± HEALTH In our modern society, digital devices, social media platforms, and artificial intelligence (AI) tools have b…+ CLIMATE The growing complexity of electric vehicle charging station (EVCS) operations—driven by grid constraints, ren…± HEALTH Objectives This study aim to develop, compare and internally validate machine-learning models for predicting…+ HEALTH Diabetes management faces a number of obstacles, such as fragmented healthcare data, privacy concerns, poor e…− SCIENCE Background Craniofacial soft tissue thickness (CFSTT) is a critical parameter in forensic facial reconstructi…+ HEALTH Background Technological innovation in total joint arthroplasty (TJA) has largely focused on intraoperative p…± HEALTH Infective endocarditis (IE) continues to be an often fatal condition despite improvements in cardiac surgical…± HEALTH Purpose of review Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of d…
TruaceTracing the truth around AISaturday, September 12, 2026
Subscribe
TRV-2026-1006Certified recordPeer-reviewed

The Translational Gap in AI for Oropharyngeal Squamous Cell Carcinoma: A TRIPOD+AI Scoping Review of Methodological Barriers to Treatment Deintensification

Rationale and objectives To map artificial intelligence (AI) and radiomics applications in computed tomography (CT), magnetic resonance imaging (MRI), and fluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT) for oropharyngeal squamous cell carcinoma (OPSCC) in the context of human papillomavirus (HPV) status and treatment deintensification, evaluate reporting quality using TRIPOD+AI (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis + Artificial Intelligen…

Health · P Space — documented harm · certified 2026-09-07 · v1 · article view · machine-readable

Current reading — problem

CT, MRI, and FDG-PET/CT-based AI/radiomics models for oropharyngeal squamous cell carcinoma lack external validation, calibration, transparency, and nodal coverage, precluding safe clinical use to guide HPV-related treatment deintensification.

What this doesn’t fix

Review scope was limited to CT, MRI, and FDG-PET/CT for HPV-oriented objectives and to PubMed/MEDLINE and Scopus searches, with findings not generalizable beyond those modalities and objectives.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-1006, v1: “The Translational Gap in AI for Oropharyngeal Squamous Cell Carcinoma: A TRIPOD+AI Scoping Review of Methodological Barriers to Treatment Deintensification.” Truvace, 2026-09-07. /record/TRV-2026-1006 (accessed at citation time). sha256 e54c698b4ac5605d…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv1e54c698b4ac5…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-1006 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.